Hormonal approaches to the chemoprevention of endocrine-dependent tumors

Endocrine-Related Cancer

Volumn 6, Issue 4, 1999, Pages 483-485

  Manni, A ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; AROMATASE INHIBITOR; ESTROGEN; ESTROGEN RECEPTOR; GONADORELIN AGONIST; PROGESTERONE; RALOXIFENE; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; HORMONAL CARCINOGENESIS; HORMONE DEPENDENCE; OSTEOPOROSIS; PREMENOPAUSE; TREATMENT PLANNING;

EID: 0033393713     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0060483     Document Type: Article

References (16)

1. Barrat J, de Lignieres B, Marpeau L, Larue L, Fournier S, Nahol K, Linares G, Giorgi H & Contesso G 1990 Effetin vivo de l'administration locale de progesterone sur l'activite mitotique des galactophores humains. Journal de Gynecologie, Obstetrique et Biologie de Reproduction 19 269-274.
2. Bulun SE, Sharda G, Rink J, Sharma S & Simpson E 1996 Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast. Journal of Clinical Endocrinology and Metabolism 81 1273-1277.
3. Chang KJ, Lee TT, Linares-Cruz G, Fournier S & de Lignieres B 1995 Influence of percutaneous administration of estradiol and progesterone on human breast epithelial cell in vivo. Fertility and Sterility 63 785.
4. Cummings SR, Norton L, Eckert S, Grady D, Cauley J, Knickerbocker R, Black DM, Nickelsen T, Glusman J & Krueger K for the MORE Investigators 1998 Raloxifene reduces the risk of breast cancer and may decrease the risk of endometrial cancer in post-menopausal women. Two-year findings from the multiple outcomes of raloxifene evalation (MORE) trial. Proceedings of the American Society of Clinical Oncology, 34th Annual Meeting, Los Angeles, CA, USA. Abstract 3.
5. Fishei B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N & other investigators 1998 Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of the National Cancer Institute 90 1371-1388.
6. Masters JRW, Drife JO & Scarisbrick JJ 1977 Cyclic variation of DNA synthesis in human breast epithelium. Journal of the National Cancer Institute 58 163.
7. Meyer JS 1977 Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritriated thymidine. Effects of menstrual phase, age, and oral contraception. Human Pathology 8 67-81.
8. Powles T, Eeles R, Ashley S, Easton D, Chang J, Dowsett M, Tidy A, Viggers J & Davey J 1998 Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 352 98-101.
9. Santen RJ, Yue W, Naftolin F, Mor G & Berstein L 1999 The potential of aromatase inhibitors in breast cancer prevention. Endocrine-Related Cancer 6 235-243.
10. Santner SJ, Pauley RL, Tait L, Kaseta J & Santen RJ 1997 Aromatase activity and expression in breast cancer and benign breast tissue stromal cells. Journal of Clinical Endocrinology and Metabolism 82 200-208.
11. Segaloff A 1973 Inhibition by progesterone of radiation-estrogen-induced mammary cancer in rat. Cancer Research 33 1136-1137.
12. Spicer DV & Pike MC 1994 Sex steroids and breast cancer prevention. Journal of the National Cancer Institute Monographs 16 139-147.
13. Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A & Pike MC 1994 Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. Journal of the National Cancer Institute 86 431-436.
14. Thomas HV, Reeves GK & Key TJA 1997 Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control 8 922-928.
15. Veronesi U, Maisonneuve P, Costa A, Sacchini V, Maltoni C, Robertson C, Rotmensz N & Boyle P on behalf of the Italian Tamoxifen Prevention Study 1998 Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Lancet 352 93-97.
16. Weitzel JN 1999 Hormonal manipulations may also reduce breast cancer risk. Journal of the National Cancer Institute 91 910.